Merck’s Keytruda scores first-in-class nod in early triple-negative breast cancer despite FDA’s prior reluctance July 27, 2021 Auto Bot News 0 Merck’s Keytruda scores first-in-class nod in early triple-negative breast cancer despite FDA’s prior reluctance aliu Tue, 07/27/2021 – 09:33
